Logo image of ACX.DE

BET-AT-HOME.COM AG (ACX.DE) Stock Fundamental Analysis

FRA:ACX - Deutsche Boerse Ag - DE000A0DNAY5 - Common Stock - Currency: EUR

2.46  -0.06 (-2.38%)

Fundamental Rating

3

ACX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 50 industry peers in the Hotels, Restaurants & Leisure industry. No worries on liquidiy or solvency for ACX as it has an excellent financial health rating, but there are worries on the profitability. ACX is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ACX has reported negative net income.
ACX had a positive operating cash flow in the past year.
In multiple years ACX reported negative net income over the last 5 years.
ACX had a positive operating cash flow in 4 of the past 5 years.
ACX.DE Yearly Net Income VS EBIT VS OCF VS FCFACX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

1.2 Ratios

ACX's Return On Assets of -15.13% is on the low side compared to the rest of the industry. ACX is outperformed by 80.00% of its industry peers.
The Return On Equity of ACX (-34.67%) is worse than 64.00% of its industry peers.
Industry RankSector Rank
ROA -15.13%
ROE -34.67%
ROIC N/A
ROA(3y)2.63%
ROA(5y)2.17%
ROE(3y)5.43%
ROE(5y)-6.73%
ROIC(3y)N/A
ROIC(5y)N/A
ACX.DE Yearly ROA, ROE, ROICACX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

ACX's Operating Margin has declined in the last couple of years.
ACX's Gross Margin of 78.97% is amongst the best of the industry. ACX outperforms 82.00% of its industry peers.
ACX's Gross Margin has been stable in the last couple of years.
ACX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.97%
OM growth 3Y-58.22%
OM growth 5Y-42.67%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.6%
ACX.DE Yearly Profit, Operating, Gross MarginsACX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

More info and screens

7

2. Health

2.1 Basic Checks

ACX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ACX remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ACX has about the same amount of shares outstanding.
The debt/assets ratio for ACX has been reduced compared to a year ago.
ACX.DE Yearly Shares OutstandingACX.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
ACX.DE Yearly Total Debt VS Total AssetsACX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

An Altman-Z score of 2.15 indicates that ACX is not a great score, but indicates only limited risk for bankruptcy at the moment.
ACX has a better Altman-Z score (2.15) than 62.00% of its industry peers.
The Debt to FCF ratio of ACX is 1.85, which is an excellent value as it means it would take ACX, only 1.85 years of fcf income to pay off all of its debts.
ACX has a better Debt to FCF ratio (1.85) than 82.00% of its industry peers.
A Debt/Equity ratio of 0.05 indicates that ACX is not too dependend on debt financing.
The Debt to Equity ratio of ACX (0.05) is better than 92.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 1.85
Altman-Z 2.15
ROIC/WACCN/A
WACC7.06%
ACX.DE Yearly LT Debt VS Equity VS FCFACX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 1.51 indicates that ACX should not have too much problems paying its short term obligations.
ACX has a better Current ratio (1.51) than 88.00% of its industry peers.
ACX has a Quick Ratio of 1.51. This is a normal value and indicates that ACX is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ACX (1.51) is better than 88.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 1.51
ACX.DE Yearly Current Assets VS Current LiabilitesACX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for ACX have decreased strongly by -232.26% in the last year.
ACX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.27%.
The Revenue for ACX have been decreasing by -18.26% on average. This is quite bad
EPS 1Y (TTM)-232.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-73.32%
Revenue 1Y (TTM)9.27%
Revenue growth 3Y-4.13%
Revenue growth 5Y-18.26%
Sales Q2Q%22.47%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.64%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACX.DE Yearly Revenue VS EstimatesACX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
ACX.DE Yearly EPS VS EstimatesACX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

ACX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 3.93, the valuation of ACX can be described as very cheap.
Based on the Price/Forward Earnings ratio, ACX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 21.38. ACX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 3.93
ACX.DE Price Earnings VS Forward Price EarningsACX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 22.66
EV/EBITDA N/A
ACX.DE Per share dataACX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ACX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BET-AT-HOME.COM AG

FRA:ACX (4/25/2025, 7:00:00 PM)

2.46

-0.06 (-2.38%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-06 2024-11-06
Earnings (Next)05-12 2025-05-12/amc
Inst Owners0.31%
Inst Owner ChangeN/A
Ins Owners58.83%
Ins Owner ChangeN/A
Market Cap17.27M
Analysts45.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 3.93
P/S 0.23
P/FCF 22.66
P/OCF 21.8
P/B 0.75
P/tB 0.81
EV/EBITDA N/A
EPS(TTM)-1.14
EYN/A
EPS(NY)0.63
Fwd EY25.46%
FCF(TTM)0.11
FCFY4.41%
OCF(TTM)0.11
OCFY4.59%
SpS10.86
BVpS3.28
TBVpS3.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.13%
ROE -34.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.97%
FCFM 1%
ROA(3y)2.63%
ROA(5y)2.17%
ROE(3y)5.43%
ROE(5y)-6.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-58.22%
OM growth 5Y-42.67%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.6%
F-Score5
Asset Turnover1.45
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 1.85
Debt/EBITDA N/A
Cap/Depr 2.37%
Cap/Sales 0.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 1.51
Altman-Z 2.15
F-Score5
WACC7.06%
ROIC/WACCN/A
Cap/Depr(3y)22.88%
Cap/Depr(5y)42.26%
Cap/Sales(3y)0.89%
Cap/Sales(5y)1.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-232.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-73.32%
EPS Next Y24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.27%
Revenue growth 3Y-4.13%
Revenue growth 5Y-18.26%
Sales Q2Q%22.47%
Revenue Next Year7.64%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-55.43%
EBIT growth 3Y-59.94%
EBIT growth 5Y-53.14%
EBIT Next Year80%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y371.17%
FCF growth 3Y-55.42%
FCF growth 5Y-51.16%
OCF growth 1Y661.54%
OCF growth 3Y-57.74%
OCF growth 5Y-51.62%